2017-10-10 22:47:52 UTC

Apply Biomarkers to Better Target Therapies to IBD Patients

Oct. 12, 2017

Dr. Lee A. Denson will present his findings on biomarkers in Las Vegas at the Crohn’s & Colitis Congress.

Science and treatment advances are moving fast in inflammatory bowel diseases (IBD), and it is imperative to stay up-to-date and apply the latest research and clinical algorithms to improve care for patients. Hear from foremost IBD researchers and practitioners at the Crohn’s & Colitis Congress™ on Jan. 18-20, 2018 in Las Vegas, as you learn alongside multi-disciplinary IBD professionals to form an all-inclusive care perspective.

In Dr. Lee A. Denson’s presentation Biomarkers for Precision Medicine, you’ll learn how to apply current and upcoming biomarkers in clinical practice to better target therapies to individual patients. Recent studies have validated biomarkers that can be used now to improve patient outcomes and guide therapeutic choices.

The Crohn’s & Colitis Congress is a partnership of the Crohn’s & Colitis Foundation and AGA. Learn more, submit an abstract and register today at www.crohnscolitiscongress.org.

More on Crohn's Disease

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

How Will Translational Advances in Pediatric IBD Affect Practices?

Oct. 17, 2017

Dr. Rosen will discuss how new findings can make a difference for pediatric IBD patients at the Crohn’s & Colitis Congress.

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.